Larenks kanseri tedavi sonuçları: Sağkalım ve yaşam kalitesi değerlendirilmesi

Amaç: Larenks kanserlerinin tedavi yaklaşımına katkıda bulunmak için larenks kanseri cerrahi sonuçlarımız ve hastaların ameliyat sonrası yaşam kaliteleri değerlendirildi.Hastalar ve Yöntemler: Geriye dönük yapılan bu klinik çalışmaya 43 larenks kanserli hasta 38 erkek, 5 kadın; ort. yaş 57.6 yıl; dağılım 34-84 yıl dahil edildi. Hastaların 29’una total larenjektomi/near total larenjektomi TL/NTL , 13’üne suprakrikoid larenjektomi SKL ve bir hastaya da supraglottik larenjektomi uygulandı. Otuz dokuz hastaya boyun diseksiyonu uygulandı. İki hastaya ameliyat öncesi, 11 hastaya ameliyat sonrası, radyoterapi RT uygulandı. Hastalar yaş, cinsiyet, sigara-alkol kullanımı, tümörün yerleşimi-histopatolojisi-evresi, cerrahi ve RT, ameliyat sonrası komplikasyonlar ve sağkalım açısından değerlendirildi. Değerlendirmede yaşam kalitesi QLQ-C30 ve QLQ-H ve N35 anketleri kullanıldı, hayatta olan ve anketleri kendi dolduran 26 hastanın formu değerlendirildi.Bulgular: Ameliyat sonrası komplikasyon olarak en sık görülen farengokütanöz fistül %41.3 , sadece TL/NTL hastalarında gelişti. Ameliyat sonrası hastanede kalış süresi ortalama 21.2 gün idi. Larenks koruma, peristomal nüks ve lokal nüks oranları sırasıyla %64.3, %6.9 ve %9.3 olarak saptandı. Genel sağkalım oranı %88.8 ve ortalama sağkalım süresi ise 62.4 ay olarak bulundu. Yaşam kalitesinin değerlendirmesinde, konuşma sorunları p

Larynx cancer treatment results: survive and quality of life assessment

Objectives: To make a contribution to the treatment modality of larynx cancer, we evaluated our surgical outcomes of the patients with larynx cancer and their quality of life in the postoperative period. Patients and Methods: Forty-three patients 38 males, 5 females; mean age 57.6 years; range 34 to 84 years with larynx cancer were included in this retrospective clinical study. Total laryngectomy/near total laryngectomy TL/NTL was performed in 29 patients, supracricoid laryngectomy in 13 patients and supraglottic laryngectomy in one patient. Neck dissection performed in 39 patients. Two patients had preoperative and eleven patients had postoperative radiotherapy RT . The patients were evaluated with respect to age, sex, smoking, alcohol consumption, localizationdifferentiation-stage of the tumor, surgery and RT, postoperative complications and survival. QLQ-C30 and QLQ-H and N35 questionnaires were used and the results of 26 patients who were alive and filled in the questionnaires themselves were evaluated. Results: The most frequent postoperative complication was pharyngocutaneous fistula 41.3% , which occurred only in TL/NTL patients. Mean postoperative hospitalization time was 21.2 days. Laryngeal preservation, peristomal recurrence and locoregional recurrence rates were 64.3%, 6.9% and 9.3% respectively. Overall survival rate was 88.8%. Mean survival time was 62.4 months. In quality of life assessment, speech problem p0.05 . Conclusion: Our surgical outcomes are compatible with the previous studies. Although the larynx preservation had a positive effect on the speech, it did not affect other quality of life parameters. In addition, having a permanent tracheostomy increased cough index markedly. We emphasize that multi-institutional prospective quality of life studies comparing different treatment methods for similar stage tumors are essential in defining the optimal management strategy in patients with larynx cancer.

___

  • Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951–62.
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
  • Morton RP, Izzard ME. Quality-of-life outcomes in head and neck cancer patients. World J Surg 2003;27:884-9.
  • World Health Organization. WHO Health Promotion Glossary 1998. WHO/HPR/HEP/98.1, World Health Organization, Geneva, 1994. Retrieved Oct. 2006 Available from: http://www.healthnetworks.health. wa.gov.au/publications/docs/06-10-04_CNDU_ Glossary.pdf.
  • Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001;322:1357-60.
  • Trivedi NP, Swaminathan DK, Thankappan K, Chatni S, Kuriakose MA, Iyer S. Comparison of quality of life in advanced laryngeal cancer patients after con- current chemoradiotherapy vs total laryngectomy. Otolaryngol Head Neck Surg 2008;139:702-7.
  • Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a qual- ity-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
  • Available from: http://www.eortc.be/home/qol/ downloads/f/SCManualQLQ-C30.pdf
  • Ampil FL, Nathan CO, Caldito G, Lian TF, Aarstad RF, Krishnamsetty RM. Total laryngectomy and postop- erative radiotherapy for T4 laryngeal cancer: a 14-year review. Am J Otolaryngol 2004;25:88-93.
  • Frederick L. Greene, AJCC cancer staging atlas. 6th ed. Chicago: Springer Verlag; 2006.
  • Erdamar B, Sütoğlu Y, Kıyak E, Sunay T, Katırcıoğlu S, Güven M ve ark. Cerrahi tedavi uygulanan larenks kanserli hastaların uzun dönemde yaşam kaliteleri- nin değerlendirilmesi. Kulak Burun Bogaz Ihtis Derg 2001;8:219-25.
  • Nordgren M, Abendstein H, Jannert M, Boysen M, Ahlner-Elmqvist M, Silander E, et al. Health-related quality of life five years after diagnosis of laryngeal car- cinoma. Int J Radiat Oncol Biol Phys 2003;56:1333-43.
  • Müller R, Paneff J, Köllner V, Koch R. Quality of life of patients with laryngeal carcinoma: a post-treatment study. Eur Arch Otorhinolaryngol 2001;258:276-80.
  • Molina Ruiz del Portal JM, Fernández-Crehuet Serrano MJ, Caballero Villarraso J, Gutiérrez Bedmar M, Gómez Gracia E, Fernández-Crehuet Navajas J. Quality of life in patients treated for early laryngeal cancer, in healthy people and in those with other associated pathologies. Acta Otorrinolaringol Esp 2004;55:381-6.
  • Weinstein GS, El-Sawy MM, Ruiz C, Dooley P, Chalian A, El-Sayed MM, et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngec- tomy. Laryngoscope 2001;111:191-9.
  • Finizia C, Hammerlid E, Westin T, Lindström J. Quality of life and voice in patients with laryngeal car- cinoma: a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope 1998;108:1566-73.
  • Dufour X, Hans S, De Mones E, Brasnu D, Ménard M, Laccourreye O. Local control after supracricoid partial laryngectomy for “advanced” endolarynge- al squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 2004;130:1092-9.
  • Hall FT, O’Brien CJ, Clifford AR, McNeil EB, Bron L, Jackson MA. Clinical outcome following total larynge- ctomy for cancer. ANZ J Surg 2003;73:300-5.
  • Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116(Suppl 111):1-13.
  • Sessions DG, Lenox J, Spector GJ. Supraglottic larynge- al cancer: analysis of treatment results. Laryngoscope 2005;115:1402-10.
  • Lavelle RJ, Maw AR. The aetiology of post-laryngecto- my pharyngo-cutaneous fistulae. J Laryngol Otol 1972; 86:785-93.
  • Soylu L, Kiroglu M, Aydogan B, Cetik F, Kiroglu F, Akçali C, et al. Pharyngocutaneous fistula following laryngectomy. Head Neck 1998;20:22-5.
  • Akduman D, Naiboğlu B, Uslu C, Oysu C, Tek A, Sürmeli M, et al. Pharyngocutaneous fistula after total larynge- ctomy: incidence, predisposing factors, and treatment. Kulak Burun Bogaz Ihtis Derg 2008;18:349-54.
  • Yuceturk SAV, Egilmez M, Ozkaya D, Ü Filiz. Functional outcome after subtotal reconstructive laryngectomy. Kulak Burun Bogaz Ihtis Derg 1999;6:291-4.
  • Braz DS, Ribas MM, Dedivitis RA, Nishimoto IN, Barros AP. Quality of life and depression in patients undergoing total and partial laryngectomy. Clinics (Sao Paulo) 2005;60:135-42.